, Tracking Stock Market Picks
Enter Symbol:
Remedent, Inc. (REMI) [hlAlert]

down 82.85 %

Remedent (REMI) rated Buy by MDB Capital Group

Posted on: Monday,  Aug 25, 2008  2:25 PM ET by MDB Capital Group

MDB Capital Group rated Buy Remedent, Inc. (OTCBB: REMI) on 08/25/2008, when the stock price was $1.75. Since
then, Remedent, Inc. has lost 82.86% as of 08/27/2015's recent price of $0.30.
If you would have followed this MDB Capital Group's recommendation on REMI, you would have lost 82.85% of your investment in 2558 days.

Remedent, Inc. (Remedent) is a manufacturer of cosmetic dentistry products in Europe. The Company is a manufacturer and distributor of cosmetic dentistry products, including a full line of professional dental and retail over-the-counter (OTC) tooth whitening products which are distributed in Europe, in Asia and the United States. Remedent manufactures many of its products in its facility in Deurle, Belgium, as well as outsourced manufacturing in China. The Company distributes its products using both its own internal sales force and through the use of third party distributors. It has established dealers in 35 countries encompassing, Europe, Asia, Latin America, the Pacific Rim and the Middle East.

MDB Capital has strives to be the leading micro-cap research firm. Our focus is on companies between $40-$200MM in market capitalization that are not widely covered by other research firms. Our objective in following this sector is to provide our investors with idea that lead to above markets returns. MDB strives to provide insightful, independent and performance-oriented research. We strictly maintain a pure research environment, where solid research opinions are formed by our analysts' thorough evaluations, rather than influenced by investment banking relationships.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/25/2008 2:25 PM Buy
as of 8/27/2015
1 Week up  0.33 %
1 Month down  -12.02 %
3 Months up  3.80 %
1 YTD up  70.45 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy